FDA data Registry peer set 6 peers FDA shortage listed

Alternatives to desipramine

FDA shortage status is active for desipramine; 6 same-class SPL records are listed below for registry comparison only.

Brand: Norpramin

Tricyclic Antidepressant (TCA) Prescription 6 alternatives found

desipramine class peers while FDA lists an active shortage

desipramine (Norpramin) is on an FDA shortage listing while 6 other Tricyclic Antidepressant (TCA) SPL records remain in this registry peer set (class inventory 7). Labeled indication field for desipramine: Desipramine is used to treat depression.

Top FAERS reaction fields for desipramine total 743 reports across 10 reactions, set beside amitriptyline, clomipramine, doxepin. Counts are exposure-weighted submissions, not per-patient risk.

About desipramine

Desipramine is a medicine used to treat depression. It belongs to a class of drugs called tricyclic antidepressants.

Used for: Desipramine is used to treat depression. Depression can cause feelings of sadness, loss of interest, and trouble functioning in daily life. This medicine can help improve your mood and overall well-being.

6 Tricyclic Antidepressant (TCA) peers (wide set)

Compare desipramine vs amitriptyline side-by-side →

desipramine vs amitriptyline & clomipramine · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between desipramine and amitriptyline, clomipramine, doxepin in this extract (1,357-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect desipramine amitriptylineclomipraminedoxepin
Fatigue 119 1,371 136 599
Completed Suicide 116 - - 613
Nausea 77 1,434 173 557
Headache 70 1,381 - 482
Weight Increased 68 - - -
Dizziness 63 1,153 136 405
Toxicity To Various Agents 60 - - 801
Pain 59 1,565 - 527

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

desipramine shortage vs Tricyclic Antidepressant (TCA) peer index

Shortage status

FDA shortage listing is active for desipramine (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for desipramine while peers remain indexed?
Yes - desipramine matched an active FDA shortage listing (To Be Discontinued) while 6 other Tricyclic Antidepressant (TCA) SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full desipramine profile →

Field note for desipramine: see also the generic vs brand label guide when reading Norpramin SPL strings.